-
Tytuł:
-
Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice.
-
Autorzy:
-
Cho DH; Department of Neurology, Konkuk University Medical Center, and Department of Pharmacology, Center for Geriatric Neuroscience Research, SMART Institute of Advanced Biomedical Science, and Gwangjin-gu, Seoul 143-701, Korea; Department of Pharmacology, School of Medicine, Eulji University, Jung-gu, Daejeon 301-746, Korea.
Park JH; Department of Molecular Medicine, Ewha Womans University Medical School, Yangcheon-gu, Seoul 158-710, Korea.
Joo Lee E; Department of Neurology, Konkuk University Medical Center, and Department of Pharmacology, Center for Geriatric Neuroscience Research, SMART Institute of Advanced Biomedical Science, and Gwangjin-gu, Seoul 143-701, Korea.
Jong Won K; Department of Medical Science, Institute of Functional Genomics, Konkuk University School of Medicine, Chungju 380-701, Korea.
Lee SH; Department of Microbiology, Chungbuk National University, Heungduk-gu, Cheongju 361-763, Korea.
Kim YH; Department of Microbiology, Chungbuk National University, Heungduk-gu, Cheongju 361-763, Korea.
Hwang S; Department of Molecular Medicine, Ewha Womans University Medical School, Yangcheon-gu, Seoul 158-710, Korea.
Ja Kwon K; Department of Neurology, Konkuk University Medical Center, and Department of Pharmacology, Center for Geriatric Neuroscience Research, SMART Institute of Advanced Biomedical Science, and Gwangjin-gu, Seoul 143-701, Korea.
Young Shin C; Department of Neurology, Konkuk University Medical Center, and Department of Pharmacology, Center for Geriatric Neuroscience Research, SMART Institute of Advanced Biomedical Science, and Gwangjin-gu, Seoul 143-701, Korea.
Song KH; Department of Internal Medicine, Konkuk University School of Medicine, Gwangjin-gu, Seoul 143-701, Korea.
Jo I; Department of Molecular Medicine, Ewha Womans University Medical School, Yangcheon-gu, Seoul 158-710, Korea. Electronic address: .
Han SH; Department of Neurology, Konkuk University Medical Center, and Department of Pharmacology, Center for Geriatric Neuroscience Research, SMART Institute of Advanced Biomedical Science, and Gwangjin-gu, Seoul 143-701, Korea. Electronic address: .
-
Źródło:
-
Free radical biology & medicine [Free Radic Biol Med] 2014 Nov; Vol. 76, pp. 96-106. Date of Electronic Publication: 2014 Aug 19.
-
Typ publikacji:
-
Journal Article; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Tarrytown, NY : Elsevier Science
Original Publication: New York : Pergamon, c1987-
-
MeSH Terms:
-
Anticonvulsants/*pharmacology
Aorta/*metabolism
Endothelium, Vascular/*metabolism
Nitric Oxide/*metabolism
Nitric Oxide Synthase Type III/*metabolism
Serine/*metabolism
Valproic Acid/*pharmacology
Animals ; Aorta/cytology ; Aorta/drug effects ; Blotting, Western ; Cattle ; Cell Differentiation/drug effects ; Cell Proliferation/drug effects ; Cells, Cultured ; Cyclin-Dependent Kinase 5/genetics ; Cyclin-Dependent Kinase 5/metabolism ; Endothelium, Vascular/cytology ; Endothelium, Vascular/drug effects ; Fluorescent Antibody Technique ; Immunoenzyme Techniques ; Immunoprecipitation ; Male ; Mice ; Mice, Inbred ICR ; Nitric Oxide Synthase Type III/genetics ; Phosphorylation/drug effects ; RNA, Messenger/genetics ; Reactive Oxygen Species/metabolism ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; SH2 Domain-Containing Protein Tyrosine Phosphatases ; Signal Transduction/drug effects ; Surface Plasmon Resonance
-
Contributed Indexing:
-
Keywords: Cyclin-dependent kinase 5; Endothelial nitric oxide synthase; Free radicals; Histone deacetylase; Nitric oxide; SH2 domain-containing protein tyrosine phosphatase 1; Valproic acid
-
Substance Nomenclature:
-
0 (Anticonvulsants)
0 (RNA, Messenger)
0 (Reactive Oxygen Species)
31C4KY9ESH (Nitric Oxide)
452VLY9402 (Serine)
614OI1Z5WI (Valproic Acid)
EC 1.14.13.39 (Nitric Oxide Synthase Type III)
EC 2.7.11.1 (Cyclin-Dependent Kinase 5)
EC 3.1.3.48 (SH2 Domain-Containing Protein Tyrosine Phosphatases)
-
Entry Date(s):
-
Date Created: 20140824 Date Completed: 20150825 Latest Revision: 20161125
-
Update Code:
-
20240104
-
DOI:
-
10.1016/j.freeradbiomed.2014.07.043
-
PMID:
-
25150199
-
Valproic acid (VPA) with its inhibitory activity of histone deacetylase has been used in the treatment of epilepsy and bipolar disorder associated with cerebrovascular dysfunction. Because nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays a role in the maintenance of vascular function, NO is likely to mediate VPA׳s drug effect, but its effect on NO production remains controversial. We investigated whether and how VPA regulates NO production in bovine aortic endothelial cells (BAECs) and mice. VPA increased NO production in BAECs, which was accompanied by a decrease in phosphorylation of eNOS at serine 116 (eNOS-Ser(116)) and cyclin-dependent kinase 5 at tyrosine 15 (CDK5-Tyr(15)). Ectopic expression of p25, a CDK5 activator, restored the VPA-inhibited eNOS-Ser(116) phosphorylation. In silico analysis revealed that the CDK5-Tyr(15) residue might be a substrate for SH2 domain-containing protein tyrosine phosphatase 1 (SH-PTP1), and CDK5 actually interacted with SH-PTP1. VPA increased SH-PTP1 expression and its activity. Stibogluconate, a specific SH-PTP1 inhibitor, reversed the VPA-inhibited phosphorylation of CDK5-Tyr(15) and eNOS-Ser(116). Knockdown of SH-PTP1 using small interfering RNA also reversed all the observed effects of VPA. Finally, both serum NO level and acetylcholine-induced aortic relaxation increased in VPA-medicated male mice. These increases were accompanied by increased SH-PTP1 expression and decreased phosphorylation of CDK5-Tyr(15) and eNOS-Ser(116) in mouse aortas. In conclusion, VPA increases NO production by inhibiting the CDK5-Tyr(15)-eNOS-Ser(116) phosphorylation axis; this process is mediated by SH-PTP1. VPA may be useful in the treatment of NO-related cerebrocardiovascular diseases.
(Copyright © 2014 Elsevier Inc. All rights reserved.)
